CSPC pharmaceutical acquires shares for employee award scheme

CSPC Pharmaceutical Group Limited announced that on October 15, 2025, the trustee of its restricted share award scheme acquired 504,000 shares on-market. These shares will be held in trust for the benefit of selected participants under the scheme, which was originally adopted on August 20, 2018, and subsequently amended on May 21, 2024. The purchase represents approximately 0.004% of the existing total number of shares in issue.

The shares were bought at an average price of HK$8.8948 per share, bringing the total consideration for this transaction to approximately HK$4,483,000. Following this purchase, the trustee now holds a balance of 109,504,000 shares for the scheme.

The company’s board retains the discretion to determine the number of shares to be awarded to participants and the volume of future on-market share purchases under the scheme, aligning with its ongoing commitment to incentivizing its workforce.